kwic
potential
potential
right
off
ON
214
1
100
500
strict
ELIZA cgi-bash version rev. 1.90
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for potential out of >500 occurrences
545945 occurrences (No.21 in the rank) during 5 years in the PubMed. [cache]
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to potential]
545945 occurrences (No.21 in the rank) during 5 years in the PubMed. [cache]
| 214) Taken together, these results indicate that (R)-TEMOSPho will be useful for dissecting the molecular mechanisms of megakaryocytic differentiation, and that this class of compounds represents potential therapeutic reagents for thrombocytopenia. |
| PMID:23166016 DOI:10.1002/term.1628 |
| 2015 Journal of tissue engineering and regenerative medicine |
| * 2-(trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate promotes megakaryocytic differentiation of myeloid leukaemia cells and primary human CD34⁺ haematopoietic stem cells. |
| - In this study we showed that 2-(trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate [(R)-TEMOSPho], a derivative of an organic chemical identified from a natural product library, promotes highly efficient differentiation of megakaryocytes. Specifically, (R)-TEMOSPho induces cell cycle arrest, cell size increase and polyploidization from K562 and HEL cells, which are used extensively to model megakaryocytic differentiation. In addition, megakaryocyte-specific cell surface markers showed a dramatic increase in expression in response to (R)-TEMOSPho treatment. Importantly, we demonstrated that such megakaryocytic differentiation can also be induced from primary human CD34(+) haematopoietic stem cells. Activation of the PI3K-AKT pathway and, to a lesser extent, the MEK-ERK pathway appears to be required for this process, as blocking with specific inhibitors interferes with the differentiation of K562 cells. A subset of (R)-TEMOSPho-treated K562 cells undergoes spontaneous apoptosis and produces platelets that are apparently functional, as they bind to fibrinogen, express P-selectin and aggregate in response to SFLLRN and AYPGFK, the activating peptides for the PAR1 and PAR4 receptors, respectively. Taken together, these results indicate that (R)-TEMOSPho will be useful for dissecting the molecular mechanisms of megakaryocytic differentiation, and that this class of compounds represents potential therapeutic reagents for thrombocytopenia. |
[
right
kwic]
(1)67  of |
(15)4 effects |
(29)2 by |
(43)2 mediator |
| (2)39 to |
(16)4 guardian |
(30)2 clinical |
(44)2 new |
| (3)35 for |
(17)4 mechanism |
(31)2 confounders |
(45)2 pathways |
| (4)14 *null* | (18)4 mechanisms |
(32)2 confounders, |
(46)2 perils |
| (5)13 in |
(19)3 adverse |
(33)2 directions |
(47)2 preventive |
| (6)10 as |
(20)3 applications |
(34)2 drug |
(48)2 risks |
| (7)10 risk |
(21)3 association |
(35)2 factors |
(49)2 than |
| (8)8 role |
(22)3 cytotoxicity |
(36)2 future |
(50)2 therapy |
| (9)8 use |
(23)3 genotoxic |
(37)2 harm |
(51)2 toxicity |
| (10)7 and |
(24)3 influence |
(38)2 hazards |
(52)2 vaccine |
| (11)7 therapeutic |
(25)3 pitfalls |
(39)2 impact |
(53)2 was |
| (12)6 benefits |
(26)3 utility |
(40)2 is |
|
| (13)5 health |
(27)3 value |
(41)2 issues |
|
| (14)5 predictors |
(28)2 biomarker |
(42)2 maximum |
add keyword
--- WordNet output for potential ---